View Article

Abstract

Nanobots are emerging as a transformative technology in cancer therapy, offering innovative strategies for targeted treatment and enhanced drug delivery. These nanoscale robots can be engineered to navigate the complex tumor microenvironment, allowing for precise targeting of cancer cells while minimizing damage to healthy tissues. Utilizing various materials, such as lipids, polymers, and DNA, nanobots can be designed to perform specific functions, including drug release, imaging, and real-time monitoring of tumor dynamics. One of the key advantages of nanobots is their ability to deliver chemotherapeutic agents directly to tumor sites, improving drug efficacy and reducing systemic side effects. Additionally, they can be programmed to respond to specific biochemical signals, ensuring that therapeutic interventions are activated only in the presence of cancerous cells. This specificity enhances treatment outcomes and paves the way for personalized medicine approaches.Preclinical studies have demonstrated the potential of nanobots to improve therapeutic efficacy, enhance imaging capabilities, and facilitate combination therapies. However, challenges such as biocompatibility, toxicity, and the development of effective delivery systems remain to be addressed. Continued research and development in this field hold promise for the future of cancer therapy, potentially leading to more effective, less invasive treatment options.

Keywords

Nanobot, tumor, cancer therpy, targeted drug delivery.

Introduction

Patients with metastatic cancer frequently do not respond well to the traditional methods of cancer treatment, which are restricted to radiation, medication chemotherapy, and surgery. They cause a number of detrimental side effects that accompany these treatments by concurrently damaging several healthy tissues. Since the nanoparticles improve therapeutic efficacy and provide significant advantages for targeted drug delivery directly to malignant cells and neoplasms, they may be employed as an alternative treatment. Existing cancer treatment medications effectively destroy growing tumor cells; the main issue with current chemotherapy is not that the treatments are ineffective, but rather that the body cannot withstand the drug concentrations needed to eradicate the cancer cells. The aggressiveness of chemotherapy treatment is typically based on doses the patient can tolerate rather than amounts required to eradicate all malignant cells. Drug concentrations high enough to destroy the tumors can kill the patient first. According to the World Health Organization, 7.6 million people died from cancer last year, making it one of the top causes of death. In the United States, the lifetime risk of acquiring cancer is 1 in 2 for males and 1 in 3 for women. The leading cause of cancer-related mortality for both men and women is lung cancer. The study, design, production, combination, control, and use of materials, devices, and frameworks at the nanometer scale (one meter is made up of one billion nanometers) is known as nanotechnology. In industries including construction, agriculture, development, microelectronics, and healthcare, it is becoming increasingly important. An artificially created device that can freely diffuse throughout the human body and interact molecularly with particular cells is known as a nanorobot.

Various agents can be applied to nanorobots based on their intended use or tissue location. The external shell is important because it must be able to release various ideal matrices that are not hazardous at the nanoscale level and be identified as an inert coating that is a component of the body. By adjusting the hole size, various sized molecules can be released (tunable porosity). Silica is an example of a molecule with a hard shell. Simple chemical techniques can readily functionalize the surface, but the most crucial factor is that the silica is not biodegradable, allowing for prolonged bodily activity. With the use of chemotactic sensors, certain chemicals and cells might be detected and readily targeted for action. Nanorobots will also be able to evaluate the surface antigens of each type of cell to determine the parent organ, if the cell is healthy, and nearly all other information about the cell. At least 0.5 cm3 of chemical agent could be delivered specifically into cells by a 1 cm3 injection of nanorobots, and the sensors could check chemical levels to prevent an unintentional overdose.

       
            Nanobots attack on cancer cell.png
       

Fig 1: Nanobots attack on cancer cell.

Robots have become a viable alternative for the regulated and targeted distribution of medications. When compared to other traditional therapeutic administration methods of smaller sizes, the primary advantage of robotic devices is their regulated, accurate, and site-specific drug delivery capability. For the regulated and targeted administration of cells, genes, or medications, robots such as stimuli-responsive and surface-functionalized magnetic helical microswimmers can target specific single cells as well as the desired regions of the tissues. Usually, minimal changes to the physiological conditions (such as pH and temperature) at the target site trigger the mechanism of cargo/drug release in small robot-like (micro/nanorobots) without active intervention. However, complicated physiological settings or unexpected local differences may result in the delivery of potential off-target therapy.

  1. Main objectives of nanobots in cancer therpy:

1.Targeted Drug Delivery:  By delivering chemotherapy medications straight to cancer cells, nanobots can reduce harm to healthy tissues and enhance the effectiveness of treatment.

2. Early Detection: By detecting cancer signals, they can be made to enable early diagnosis and treatment.

3.  Monitoring Treatment Response: By keeping an eye on tumor markers or variations in tumor size, nanobots can give real-time feedback on how effectively a treatment is working.

4. Gene therapy: By delivering genetic material to cancer cells, certain nanobots may be able to improve immune responses or fix mutations.

5. Thermal and Radiofrequency Treatment: By heating or irradiating tumor cells specifically to cause cell death, nanobots can help with targeted radiation therapy or hyperthermia.

6. Enhancement of Immunotherapy: By delivering immune-stimulating drugs straight to the tumor site, they can be utilized to increase the immune response against cancer cells.

7. Decreased Systemic Toxicity: Nanobots can lessen the overall toxicity and adverse effects of traditional therapies by focusing treatment at the tumor site.      

  1. Types of Nanobots :

The nanobots can be classified in following some types:-

1.  DNA robots:   DNA nanobots are made of DNA strands and are capable of basic functions like medicine delivery to specific cells or molecular detection. These nanobots can be precisely assembled thanks to DNA origami techniques.

2. Microswimmers:  These nanobots use cilia or flagella to move like biological organisms, such as bacteria. They can be utilized for environmental monitoring or medicine administration because they can move across fluids.

3.magnetically controlled nanobots:  External magnetic fields are used by magnetically controlled nanobots to guide their motion. They are frequently made to carry out internal surgical procedures or to distribute drugs precisely.

4. Biohybrid nanobots : It  combine synthetic materials with biological elements, including live cells. For jobs like sensing or energy production, they can take advantage of the inherent capabilities of cells.

5. Smart Nanobots: These nanobots can change their shape in response to environmental stimuli like temperature or pH since they are outfitted with sensors and responsive materials.

6. Photothermal nanobots: These nanobots produce heat through the absorption of light for uses including cancer treatment, where localized heating aids in the destruction of malignant cells.

  1.  Ideal characteristics of Nanobots:

It will use carrier wave frequencies between 1 and 100 MHz to encode messages into acoustic sounds in order to communicate with the doctor. In a process known as self-replication, it may create several copies of itself to replace damaged units. It can also be eliminated by active scavenger systems after the task is finished by letting it excuse itself through the normal human excretory channel. Nanorobots need to be between 0.5 and 3 microns in size, having components that are 1–100 nm in size. It will have a passive, diamond exterior to shield itself from immune system attacks.

  1. Construction of nanobots:          

1. Core Framework:  A framework that offers structural stability frequently makes up a nanobot's core. Materials like DNA, polymers, or silica can be used to make this. One noteworthy method that gives you exact control over the stability and form of the nanobot is DNA origami.

2. Functional Modules: Nanobots can have a variety of modules that carry out particular tasks, like:
a. Sensing Units: To use sensors that react to particular stimuli in order to identify biological markers or changes in the environment.

b.  Actuators are devices that allow motion or action, like electrostatic actuators or structures modeled after flagella.

 

c. Systems for Drug Delivery: These systems can release therapeutic compounds in a controlled way and are frequently encased in polymeric nanoparticles or lipid-based carriers.

3. Communication Systems: Certain nanobots are built with the ability to communicate, which enables them to send and receive commands as well as information about their surroundings. Chemical signals or optical techniques can do this.

4. Energy Sources: Chemical gradients, light (via photosensitive materials), or even enzyme reactions can provide the energy needed for nanobots to function.

       
            Structure and component of nanobot.png
       

Fig 2. Structure and component of nanobot.

  1. Approches for developing’s  Nanobots:

The creation of nanobots involves a number of strategies that make use of diverse scientific theories and technological advancements. These methods can be divided into groups according to their application, function, and design. The following are some crucial methods for creating nanobots:

1. Biological Methods:

a. DNA Origami: This technique makes nanostructures out of DNA molecules. By creating particular sequences that fold into desired shapes, researchers are able to precisely regulate the construction of the nanobot.

b. Biohybrid systems are made by fusing synthetic materials with biological elements (such as cells or proteins) to enable sophisticated functions like sensing or movement in response to biological cues.

2. Artificial Methods:

a.  microfluid:  By manipulating fluids at the microscale, microfluidics allows for the creation of nanobots that can traverse and react to chemical surroundings.

b. Nanoscale Fabrication Methods: Nanoscale devices and structures are made using methods like self-assembly and lithography. These techniques enable fine-grained control over nanobots' dimensions and form.

3. Chemical Methods:

a. Chemical Motors: These nanobots move by means of chemical reactions. Catalytic reactions, for instance, can create gas bubbles that move the nanobot through a solution.

b. Smart nanomaterials: These substances react to environmental cues like temperature or pH, enabling nanobots to alter their form or discharge payloads in response to certain circumstances.

4. Mechanical Methods:

a. Self-Propelled Systems: Some nanobots are made to move on their own by utilizing cilia or flagella, which are biologically inspired systems.

       
            Approaches for developing nanobots.jpg
       

Fig 3. Approaches for developing nanobots

  1. Advantages of  nanobots used in cancer therpy:   

1. Targeted Drug Delivery:  By specifically targeting cancer cells, nanobots can reduce harm to healthy organs. This focused strategy lessens side effects while increasing chemotherapy's effectiveness.

2. Better Drug Solubility:  By increasing the solubility and bioavailability of poorly soluble medications, nanobots can open up more efficient therapy alternatives.

3. Real-time Monitoring:  Sensor-equipped nanobots can keep an eye on drug distribution and tumor surroundings in real time, providing vital information for modifying treatment regimens.

4. Combination Therapies:  They can help deliver several therapeutic agents at once, enabling combination treatments that can combat drug resistance.

5. Decreased Systemic Toxicity:  Nanobots can dramatically lower systemic toxicity by delivering medications straight to the tumor site, improving patient tolerance and quality of life throughout treatment.

6. Improved Imaging Methods: By enhancing imaging methods, nanobots can help identify and diagnose malignancies early.

       
            nanobots used in cancer drug delivery.png
       

Fig 3:  nanobots used in cancer drug delivery

  1. Disadvantages of nanobots used in cancer therapy:

1. Safety and Biocompatibility: Little is known about how nanobots may affect the human body over time. Nanobot materials may cause immunological reactions or build up in organs, raising questions regarding biocompatibility and possible toxicity.

2. Safety and Biocompatibility: Little is known about how nanobots may affect the human body over time. Nanobot materials may cause immunological reactions or build up in organs, raising questions regarding biocompatibility and possible toxicity.

3. Manufacturing and Scalability: Producing nanobots is frequently an intricate and expensive process. Accessibility and affordability may be impacted by the major hurdle of scaling up production for clinical usage.

4. Regulatory Obstacles: The market launch of nanobots may be delayed due to the strict regulatory criteria for approval. The clearance procedure for nanotechnology may be made more difficult by the absence of set rules.

5. Technical Restrictions: The therapeutic efficacy of current nanobot designs may be hampered by their inability to move, navigate, and function in the intricate environment of the human body.

  1. Application of nanobots:  

1. Photothermal Therapy: When directed correctly, nanobots may absorb light and produce heat to kill cancer cells only.

2. Gene therapy: By delivering therapeutic genes to cancer cells, nanobots may be able to stop tumor development or trigger apoptosis.

3. Enhancement of Immunotherapy: By delivering immune-modulating chemicals, nanobots can increase immune responses against malignancies.

4. Imaging and Diagnosis: By enhancing imaging methods, nanobots can help in tumor monitoring and early identification.       

       
            Application of nanobots’.jpg
       

Fig 4: Application of nanobots’

  1. CONCLUSION:

Nanobots represent an exciting frontier in cancer therapy, offering the potential for highly targeted, efficient, and minimally invasive treatment options. By leveraging the unique properties of nanotechnology, nanobots can be engineered to deliver therapeutic agents directly to cancer cells, significantly improving drug delivery precision and reducing collateral damage to healthy tissues. This targeted approach not only enhances the efficacy of treatments but also minimizes the side effects typically associated with conventional therapies like chemotherapy and radiation.

Nanobots can also be designed to monitor tumor growth in real time, providing valuable diagnostic data and allowing for adaptive treatment strategies. Additionally, they can be programmed to interact with tumor cells in a way that encourages cell death, prevents metastasis, or boosts the immune system’s response to cancer cells.

However, several challenges remain before nanobots can become widely used in clinical practice. These include ensuring their safe and efficient integration within the human body, overcoming regulatory hurdles, and minimizing potential toxicity. Further research is needed to fully understand the long-term effects and scalability of nanobot-based treatments. Overall, while still in the experimental stages, nanobots hold tremendous promise as part of a new generation of cancer therapies that could revolutionize the way we treat and manage cancer, offering more personalized and less invasive alternatives to current treatments.

REFERENCES

  1. Loukanov, Alexandre & Nikolova, Svetla & Filipov, Chavdar & Nakabayashi, Seiichiro. (2019). Nanomaterials for cancer medication: from individual nanoparticles toward nanomachines and nanorobots. Farmatsiia. 66. 10.3897/pharmacia.66.e37739.
  2. Sandeep S, GURURAJ BT, DEEPAK AY, SANDEEP S, NITISH K. Nanobotz in Cancer Detection & Trearment. Journal of Medicine and Pharmaceutical. 2015 Jun;1:7-14.
  3. Bhatt, Pankaj & Kumar, Ajeet & Shukla, Rahul. (2019). Nanorobots Recent and Future Advances in Cancer or Dentistry Therapy- A Review. American Journal of PharmTech Research. 9. 321-331. 10.46624/ajptr.2019.v9.i3.027.
  4. Rajesh J, Pavithra G, Dr. T.C. Manjunath, 2018, Design & Development of Nanobots for Cancer Cure Applications in Bio-Medical Engineering, INTERNATIONAL JOURNAL OF ENGINEERING RESEARCH & TECHNOLOGY (IJERT) NCESC – 2018 (Volume 6 – Issue 13),
  5. Suhail M, Khan A, Rahim MA, Naeem A, Fahad M, Badshah SF, Jabar A, Janakiraman AK. Micro and nanorobot-based drug delivery: an overview. J Drug Target. 2022 Apr;30(4):349-358. doi: 10.1080/1061186X.2021.1999962. Epub 2021 Nov 9. PMID: 34706620.
  6. Peer, D., Kimmelman, J., Yu, D., et al. (2007). Nanocarriers as an emerging platform for cancer therapy. Nature Nanotechnology, 2(12), 751-760.
  7. Zhang, Y., et al. (2015). Nanoparticles for cancer diagnosis and therapy. Nature Reviews Materials, 1(1), 15005.
  8. Wang, H., et al. (2016). Nanobots for tumor monitoring and therapy. Advanced Drug Delivery Reviews, 106, 103-115.
  9. Böker, A., et al. (2010). Nanomaterials for targeted drug delivery: Design and applications. Chemical Society Reviews, 39(6), 2000-2015.
  10. Huang, X., et al. (2011). Nanoparticles for thermal therapy in cancer treatment. Nanomedicine, 6(1), 125-133
  11. Fang, R. H., et al. (2017). Nanoparticle-mediated immunotherapy: A review of current strategies. Nature Reviews Immunology, 17(3), 153-168.
  12. Davis, M. E., et al. (2008). Nanoparticle therapeutics: An emerging treatment modality for cancer. Nature Reviews Drug Discovery, 7(9), 771-782.
  13. Seeman, N.C. (2003). "DNA in a material world." Nature, 421(6921), 427-431.
  14. Simmchen, J., et al. (2016). "Micro- and nanoswimmers: From basic physics to applications." Advanced Materials, 28(17), 3015-3032.
  15. Yaqoob, U., et al. (2017). "Magnetically actuated micro- and nanosystems: A review." Journal of Micro-Bio Robotics, 12(1), 3-21.                                                                                                                                    
  16. Maji, S.K., et al. (2017). "Biohybrid robots: Integrating biological tissues with engineered systems." Biomaterials, 145, 145-159.
  17. Wang, Y., et al. (2015). "Smart nanomaterials: Stimuli-responsive polymers and hydrogels." Polymer Reviews, 55(3), 551-575.
  18. Huang, P., et al. (2016). "Photothermal therapy and photothermal agents: A comprehensive review." Materials Today, 19(2), 62-78.
  19. Naik, Mudavath & Satyanarayana, Jala & Kudari, Raj & Hanumanaik, Mudavath. (2024). Nanorobots in drug delivery systems and treatment of cancer. Characterization and Application of Nanomaterials. 7. 2539. 10.24294/can.v7i2.2539.
  20. Seeman, N.C. (2010). "DNA Nanotechnology: From Structure to Function." Nature Reviews Molecular Cell Biology, 11(12), 898-910. DOI: 10.1038/nrm3010.
  21. Choi, S., et al. (2017). "Nanobots for Sensing and Treatment in Cancer." Biosensors and Bioelectronics, 89, 405-415. DOI: 10.1016/j.bios.2016.09.040.
  22. Duan, H., et al. (2016). "Nanorobots for Biomedical Applications." Advanced Healthcare Materials, 5(16), 2049-2060. DOI: 10.1002/adhm.201600376.
  23. Kumar, V., et al. (2019). "Nanobots for Drug Delivery in Cancer Treatment." Cancer Letters, 449, 205-212. DOI: 10.1016/j.canlet.2019.03.027.
  24. Liu, J., et al. (2020). "Recent Advances in Nanobots for Cancer Treatment." Materials Today, 38, 40-56. DOI: 10.1016/j.mattod.2020.01.004.
  25. Zhang, L., et al. (2016). "Designing and Building Biologically Inspired Nanorobots." Nature Biotechnology, 34(4), 420-427. DOI: 10.1038/nbt.3537.
  26. Seeman, N.C. (2010). "DNA Nanotechnology: From Structure to Function." Nature Reviews Molecular Cell Biology, 11(12), 898-910. DOI: 10.1038/nrm3010.
  27. Yin, Y., et al. (2017). "Nanobots in Cancer Therapy." Frontiers in Pharmacology, 8, 136. DOI: 10.3389/fphar.2017.00136.
  28. Duan, H., et al. (2016). "Nanorobots for Biomedical Applications." Advanced Healthcare Materials, 5(16), 2049-2060. DOI: 10.1002/adhm.201600376.
  29. Zhang, L., et al. (2016). "Designing and Building Biologically Inspired Nanorobots." Nature Biotechnology, 34(4), 420-427. DOI: 10.1038/nbt.3537.
  30. Paxton, W.F., et al. (2006). "Catalytic Nanomotors: The Effect of Size and Shape on Motion." Langmuir, 22(24), 10714-10718. DOI: 10.1021/la061180c.
  31. Kumar, V., et al. (2019). "Nanobots for Drug Delivery in Cancer Treatment." Cancer Letters, 449, 205-212. DOI: 10.1016/j.canlet.2019.03.027.
  32. Sengupta, S., et al. (2013). "Self-Propelled Nanobots for Biomedical Applications." Biotechnology Advances, 31(6), 913-925. DOI: 10.1016/j.biotechadv.2013.04.007.
  33. Mansoori, B., et al. (2017). "Nanotechnology in cancer therapy: An overview." Cancer Nanotechnology.
  34. Vashist, A., et al. (2017). "Nanoparticle-based drug delivery systems: The future of cancer therapy." Journal of Cancer Research.
  35. Feng, Q., et al. (2015). "Nanobots for targeted drug delivery in cancer treatment." Cancer Therapy Reviews.
  36. Khan, Y., et al. (2020). "Nanotechnology and cancer therapy: A review." Current Drug Delivery.
  37. Saha, S., et al. (2016). "Nanoparticle-based drug delivery systems: Progress and challenges." International Journal of Nanomedicine.
  38. Rosenblum, D., et al. (2018). "Progress and challenges toward nanomedicine in cancer." Nature Reviews Cancer.
  39. Hinton, T. (2015). "The Promise and Peril of Nanotechnology in Cancer Therapy." Nature Nanotechnology, 10(7), 577-583.
  40. Joudeh, N. et al. (2019). "Nanoparticle-based Drug Delivery Systems: Challenges and Future Directions." Journal of Nanobiotechnology, 17, 1-16.
  41. Lee, J. et al. (2017). "Challenges in the Production of Nanomedicine." Frontiers in Chemistry, 5, 57.
  42. Sargent, T. et al. (2018). "Regulatory Considerations for Nanomedicines." Nanomedicine: Nanotechnology, Biology, and Medicine, 14(7), 2177-2188.
  43. Cacciato, G. et al. (2020). "Design and Fabrication of Nanobots for Cancer Therapy: Current Challenges and Future Prospects." Nanotechnology Reviews, 9(1), 24-39.
  44. M. M. K. F. Alshahrani et al. (2020). "Nanobots in photothermal therapy for cancer treatment." Nanotechnology Reviews, 9(1), 1259-1277. DOI: 10.1515/ntrev-2020-0043
  45. S. H. Lee et al. (2018). "Nanoparticle-based gene delivery systems for cancer therapy." Advanced Drug Delivery Reviews, 126, 88-107. DOI: 10.1016/j.addr.2018.04.013
  46. A. F. A. H. G. M. Morad et al. (2021). "Nanobots and Immunotherapy: A Novel Approach in Cancer Treatment." Biomaterials Science, 9(6), 2151-2169. DOI: 10.1039/D0BM01515E
  47. H. Wang et al. (2020). "Nanoparticles for cancer imaging: A review." Journal of Nanobiotechnology, 18, 1-22. DOI: 10.1186/s12951-020-00687-8

Reference

  1. Loukanov, Alexandre & Nikolova, Svetla & Filipov, Chavdar & Nakabayashi, Seiichiro. (2019). Nanomaterials for cancer medication: from individual nanoparticles toward nanomachines and nanorobots. Farmatsiia. 66. 10.3897/pharmacia.66.e37739.
  2. Sandeep S, GURURAJ BT, DEEPAK AY, SANDEEP S, NITISH K. Nanobotz in Cancer Detection & Trearment. Journal of Medicine and Pharmaceutical. 2015 Jun;1:7-14.
  3. Bhatt, Pankaj & Kumar, Ajeet & Shukla, Rahul. (2019). Nanorobots Recent and Future Advances in Cancer or Dentistry Therapy- A Review. American Journal of PharmTech Research. 9. 321-331. 10.46624/ajptr.2019.v9.i3.027.
  4. Rajesh J, Pavithra G, Dr. T.C. Manjunath, 2018, Design & Development of Nanobots for Cancer Cure Applications in Bio-Medical Engineering, INTERNATIONAL JOURNAL OF ENGINEERING RESEARCH & TECHNOLOGY (IJERT) NCESC – 2018 (Volume 6 – Issue 13),
  5. Suhail M, Khan A, Rahim MA, Naeem A, Fahad M, Badshah SF, Jabar A, Janakiraman AK. Micro and nanorobot-based drug delivery: an overview. J Drug Target. 2022 Apr;30(4):349-358. doi: 10.1080/1061186X.2021.1999962. Epub 2021 Nov 9. PMID: 34706620.
  6. Peer, D., Kimmelman, J., Yu, D., et al. (2007). Nanocarriers as an emerging platform for cancer therapy. Nature Nanotechnology, 2(12), 751-760.
  7. Zhang, Y., et al. (2015). Nanoparticles for cancer diagnosis and therapy. Nature Reviews Materials, 1(1), 15005.
  8. Wang, H., et al. (2016). Nanobots for tumor monitoring and therapy. Advanced Drug Delivery Reviews, 106, 103-115.
  9. Böker, A., et al. (2010). Nanomaterials for targeted drug delivery: Design and applications. Chemical Society Reviews, 39(6), 2000-2015.
  10. Huang, X., et al. (2011). Nanoparticles for thermal therapy in cancer treatment. Nanomedicine, 6(1), 125-133
  11. Fang, R. H., et al. (2017). Nanoparticle-mediated immunotherapy: A review of current strategies. Nature Reviews Immunology, 17(3), 153-168.
  12. Davis, M. E., et al. (2008). Nanoparticle therapeutics: An emerging treatment modality for cancer. Nature Reviews Drug Discovery, 7(9), 771-782.
  13. Seeman, N.C. (2003). "DNA in a material world." Nature, 421(6921), 427-431.
  14. Simmchen, J., et al. (2016). "Micro- and nanoswimmers: From basic physics to applications." Advanced Materials, 28(17), 3015-3032.
  15. Yaqoob, U., et al. (2017). "Magnetically actuated micro- and nanosystems: A review." Journal of Micro-Bio Robotics, 12(1), 3-21.                                                                                                                                    
  16. Maji, S.K., et al. (2017). "Biohybrid robots: Integrating biological tissues with engineered systems." Biomaterials, 145, 145-159.
  17. Wang, Y., et al. (2015). "Smart nanomaterials: Stimuli-responsive polymers and hydrogels." Polymer Reviews, 55(3), 551-575.
  18. Huang, P., et al. (2016). "Photothermal therapy and photothermal agents: A comprehensive review." Materials Today, 19(2), 62-78.
  19. Naik, Mudavath & Satyanarayana, Jala & Kudari, Raj & Hanumanaik, Mudavath. (2024). Nanorobots in drug delivery systems and treatment of cancer. Characterization and Application of Nanomaterials. 7. 2539. 10.24294/can.v7i2.2539.
  20. Seeman, N.C. (2010). "DNA Nanotechnology: From Structure to Function." Nature Reviews Molecular Cell Biology, 11(12), 898-910. DOI: 10.1038/nrm3010.
  21. Choi, S., et al. (2017). "Nanobots for Sensing and Treatment in Cancer." Biosensors and Bioelectronics, 89, 405-415. DOI: 10.1016/j.bios.2016.09.040.
  22. Duan, H., et al. (2016). "Nanorobots for Biomedical Applications." Advanced Healthcare Materials, 5(16), 2049-2060. DOI: 10.1002/adhm.201600376.
  23. Kumar, V., et al. (2019). "Nanobots for Drug Delivery in Cancer Treatment." Cancer Letters, 449, 205-212. DOI: 10.1016/j.canlet.2019.03.027.
  24. Liu, J., et al. (2020). "Recent Advances in Nanobots for Cancer Treatment." Materials Today, 38, 40-56. DOI: 10.1016/j.mattod.2020.01.004.
  25. Zhang, L., et al. (2016). "Designing and Building Biologically Inspired Nanorobots." Nature Biotechnology, 34(4), 420-427. DOI: 10.1038/nbt.3537.
  26. Seeman, N.C. (2010). "DNA Nanotechnology: From Structure to Function." Nature Reviews Molecular Cell Biology, 11(12), 898-910. DOI: 10.1038/nrm3010.
  27. Yin, Y., et al. (2017). "Nanobots in Cancer Therapy." Frontiers in Pharmacology, 8, 136. DOI: 10.3389/fphar.2017.00136.
  28. Duan, H., et al. (2016). "Nanorobots for Biomedical Applications." Advanced Healthcare Materials, 5(16), 2049-2060. DOI: 10.1002/adhm.201600376.
  29. Zhang, L., et al. (2016). "Designing and Building Biologically Inspired Nanorobots." Nature Biotechnology, 34(4), 420-427. DOI: 10.1038/nbt.3537.
  30. Paxton, W.F., et al. (2006). "Catalytic Nanomotors: The Effect of Size and Shape on Motion." Langmuir, 22(24), 10714-10718. DOI: 10.1021/la061180c.
  31. Kumar, V., et al. (2019). "Nanobots for Drug Delivery in Cancer Treatment." Cancer Letters, 449, 205-212. DOI: 10.1016/j.canlet.2019.03.027.
  32. Sengupta, S., et al. (2013). "Self-Propelled Nanobots for Biomedical Applications." Biotechnology Advances, 31(6), 913-925. DOI: 10.1016/j.biotechadv.2013.04.007.
  33. Mansoori, B., et al. (2017). "Nanotechnology in cancer therapy: An overview." Cancer Nanotechnology.
  34. Vashist, A., et al. (2017). "Nanoparticle-based drug delivery systems: The future of cancer therapy." Journal of Cancer Research.
  35. Feng, Q., et al. (2015). "Nanobots for targeted drug delivery in cancer treatment." Cancer Therapy Reviews.
  36. Khan, Y., et al. (2020). "Nanotechnology and cancer therapy: A review." Current Drug Delivery.
  37. Saha, S., et al. (2016). "Nanoparticle-based drug delivery systems: Progress and challenges." International Journal of Nanomedicine.
  38. Rosenblum, D., et al. (2018). "Progress and challenges toward nanomedicine in cancer." Nature Reviews Cancer.
  39. Hinton, T. (2015). "The Promise and Peril of Nanotechnology in Cancer Therapy." Nature Nanotechnology, 10(7), 577-583.
  40. Joudeh, N. et al. (2019). "Nanoparticle-based Drug Delivery Systems: Challenges and Future Directions." Journal of Nanobiotechnology, 17, 1-16.
  41. Lee, J. et al. (2017). "Challenges in the Production of Nanomedicine." Frontiers in Chemistry, 5, 57.
  42. Sargent, T. et al. (2018). "Regulatory Considerations for Nanomedicines." Nanomedicine: Nanotechnology, Biology, and Medicine, 14(7), 2177-2188.
  43. Cacciato, G. et al. (2020). "Design and Fabrication of Nanobots for Cancer Therapy: Current Challenges and Future Prospects." Nanotechnology Reviews, 9(1), 24-39.
  44. M. M. K. F. Alshahrani et al. (2020). "Nanobots in photothermal therapy for cancer treatment." Nanotechnology Reviews, 9(1), 1259-1277. DOI: 10.1515/ntrev-2020-0043
  45. S. H. Lee et al. (2018). "Nanoparticle-based gene delivery systems for cancer therapy." Advanced Drug Delivery Reviews, 126, 88-107. DOI: 10.1016/j.addr.2018.04.013
  46. A. F. A. H. G. M. Morad et al. (2021). "Nanobots and Immunotherapy: A Novel Approach in Cancer Treatment." Biomaterials Science, 9(6), 2151-2169. DOI: 10.1039/D0BM01515E
  47. H. Wang et al. (2020). "Nanoparticles for cancer imaging: A review." Journal of Nanobiotechnology, 18, 1-22. DOI: 10.1186/s12951-020-00687-8

Photo
Badwar Onkar
Corresponding author

Matoshri Institute of Pharmacy, Dhanore, Yeola (423401)

Photo
Jagtap Krushna
Co-author

Matoshri Institute of Pharmacy, Dhanore, Yeola (423401)

Photo
Sanap Tushar
Co-author

Matoshri Institute of Pharmacy, Dhanore, Yeola (423401)

Badwar Onkar*, Jagtap Krushna, Sanap Tushar, A Review on Nanobots- A New Hope for Cancer Patients, Int. J. of Pharm. Sci., 2024, Vol 2, Issue 11, 1121-1129. https://doi.org/10.5281/zenodo.14210706

More related articles
Disruption In Modulation: Unraveling Anxiety Disor...
Ayush Kumar, Ankita Singh, Anupama Kumari, Arnab Roy, Sajid Ansar...
Nose To Brain Drug Delivery System And Its Novel A...
Nikita N. Bagade, Shripad M. Dalvi, Pranjali Ramesh Gaikwad , ...
Chalcone Derivatives As Potential Biological Activities ...
A.Sri Priya, K. Govinda Rao, A. Sri Laya, P. Devika, K. Renuka, D. Pravallika, N. Hasini, G. Venu, A...
A Review On In-Vitro Evaluation Of Antibacterial And Antioxidant Activity Of Pol...
Sonti S S Malleswara Sharma, Mane Jyothi, Atyam Vaishnavi, Avidi Mahalakshmi, ...
Polyherbal Churn For Treatment Of Diabetes...
Tushar Sanjay Bochare, Nishan Bobade , Vedant Sanjay Ganorkar , Vaishnavi Chavhan, Ashweeni Kedar, ...
Related Articles
Herbal Nanogel Formulations For Psoriasis: A Review Of Recent Advances And Futur...
Shweta Dnyandev Birajdar , Supriya dayanand Khutwad , Kishor Otari, ...
Preparation And Evaluation of Herbal Transdermal Patch for Management of Varicos...
Anjali Kide-Nandedkar, Nameera Sadiya Begum, Sudhakar Muvvala, ...
In Silico Design And ADME Study Of Novel Benzimidazole Containing Derivatives As...
Sandip S. Chaudhari , Megha R. Mahajan , Puja R. Khodape, Diksha N. Koli, Tarannum R. Sayyyad , Pras...
A Review On Nano Gel As A Novel Drug Delivery System...
Dnyaneshwari M. Bhagat, Priyanka S. Lokare , Rupali D. Bandagar, ...
Disruption In Modulation: Unraveling Anxiety Disorders And The Role Of GABA Neur...
Ayush Kumar, Ankita Singh, Anupama Kumari, Arnab Roy, Sajid Ansari, Subham Kumar Lohani, Nahida Khat...
More related articles
Disruption In Modulation: Unraveling Anxiety Disorders And The Role Of GABA Neur...
Ayush Kumar, Ankita Singh, Anupama Kumari, Arnab Roy, Sajid Ansari, Subham Kumar Lohani, Nahida Khat...
Nose To Brain Drug Delivery System And Its Novel Approaches...
Nikita N. Bagade, Shripad M. Dalvi, Pranjali Ramesh Gaikwad , ...
Disruption In Modulation: Unraveling Anxiety Disorders And The Role Of GABA Neur...
Ayush Kumar, Ankita Singh, Anupama Kumari, Arnab Roy, Sajid Ansari, Subham Kumar Lohani, Nahida Khat...
Nose To Brain Drug Delivery System And Its Novel Approaches...
Nikita N. Bagade, Shripad M. Dalvi, Pranjali Ramesh Gaikwad , ...